Find Academic Supervisors

• Genomic Biomarkers
• Thoracic Oncology
• Tumor Immunology
• +3 more

Amin Nassar, M.D., is a Clinical Fellow in Medical Oncology and Hematology at Yale School of Medicine. He holds a medical degree from the American University of Beirut and completed residency at Brigham and Women’s Hospital. His postdoctoral training under Professors David Kwiatkowski, Toni Choueiri, and Matthew Freedman at Harvard Medical School focused on genomic biomarkers across ancestral populations with cancer. Currently pursuing a PhD in tumor immunology at the Flavell lab, he is dedicated to becoming a physician-scientist specializing in thoracic oncology. His research explores genetic and epigenetic factors influencing cancer outcomes, including tumor mutational burden (TMB) recalibration across ethnicities, KRAS mutations, and immune checkpoint inhibitor efficacy in diverse populations. He has authored over 50 peer-reviewed articles in high-impact journals like Nature Communications , Cancer Cell , and New England Journal of Medicine . Nassar serves on editorial boards for Frontiers in Oncology , Molecular Biology Reports , and Translational Oncology , and has received awards including the ASH Achievement Award (2022) and Alpha Omega Alpha (2016). His work bridges clinical practice and research, emphasizing health equity and precision medicine.

• Pediatric Endocrinology
• Child Health and Diseases
• Thyroid Disorders
• +5 more

Mehmet Keskin is a Professor at Gaziantep University Faculty of Medicine, Department of Internal Medicine and Department of Child Health and Diseases. His primary research focus is in Pediatric Endocrinology, with particular expertise in thyroid disorders, diabetes, growth disorders, and adrenal diseases in children. Dr. Keskin completed his medical education at Hacettepe University Faculty of Medicine (1986-1995), followed by medical specialization in Child Health and Diseases at the same institution (1996-2001). He further specialized in Pediatric Endocrinology at Erciyes University (2002-2005). Since 2006, he has served as a Professor at Gaziantep University. His research interests span multiple areas of pediatric endocrinology including thyroid disorders (particularly congenital hypothyroidism and thyroid nodules), diabetes mellitus (especially Type 1 diabetes and its complications), adrenal disorders (including congenital adrenal hyperplasia), growth disorders, puberty disorders, and metabolic diseases. His work often focuses on the Turkish population, particularly in Southeastern Anatolia. Dr. Keskin has published extensively with over 150 articles in international journals, with recent work focusing on genetic aspects of endocrine disorders, genotype-phenotype correlations, and epidemiological studies of endocrine conditions in Turkish children. His research shows a strong emphasis on translating genetic findings into clinical practice and improving screening programs for endocrine disorders. He has authored or co-authored 5 book chapters on pediatric endocrinology topics, including works on thyroid diseases, adrenal disorders, and metabolic diseases in children. Dr. Keskin's work has significant clinical implications for the diagnosis and management of pediatric endocrine disorders in Turkey and contributes to the global understanding of these conditions, particularly in understudied populations.

• Animal Genetics
• Livestock Genomics
• Welfare-focused Breeding
• +4 more

Nadine Buys serves as a full Professor in the Department of Biosystems within the Faculty of Bioscience Engineering at KU Leuven. She is actively engaged in multiple institutional roles including membership in the BioAsyst Division and Leuven One Health Institute, while chairing the Assessment Committee of the Faculty of Bioscience Engineering. Her work spans animal genetics, genomics, and welfare-focused breeding across multiple species. Her research primarily focuses on livestock genomics with emphasis on welfare-driven breeding strategies. Key areas include disease resistance in farm animals (particularly psoroptic mange in cattle and PRRS in pigs), transcriptomic analysis of production traits, and genetic selection for improved animal health. Her work integrates advanced genomic technologies to address congenital disorders, growth uniformity, and reproductive efficiency in pigs, cattle, and horses. The recent publication portfolio demonstrates a strong trend toward applied genomics across diverse species. Her team frequently employs transcriptome analysis to identify genetic markers for feed resilience, disease resistance, and congenital disorders. Notable patterns include cross-species applications of genomic selection (from cattle to insects), integration of welfare considerations into breeding programs, and methodological innovations in performance evaluation for livestock and sport animals. Professor Buys actively supervises research students and leads numerous significant projects including GenoBreed (welfare-driven livestock breeding), StrongSheep (healthy sheep breeding), and initiatives targeting genomic solutions for insect protein production. Her grant portfolio demonstrates substantial funding for welfare-focused genomic applications across multiple farm animal species. She contributes to institutional governance through multiple committees including the Faculty Council of Bioscience Engineering and Departmental Council for Biosystems. Her laboratory work centers around the Animal and Human (A2H) unit at Arenberg Castle, with strong connections to KU Leuven's One Health Institute, reflecting her integrated approach to animal and human health challenges.

Nancy DuView profile

Associate Professor

• Cancer Research
• Oncology
• Metastasis
• +5 more

Nancy Du is an Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College specializing in cancer metastasis mechanisms. She holds the Mildred L. and John F. Rasweiler Research Scholar in Cancer Research title and maintains active collaborations with Northwell Health through professional services. B.S., National Tsing Hua University (Taiwan) Ph.D., State University of New York at Stony Brook Her research focuses on: Bcl-xL's non-apoptotic role in metastasis RHAMM isoform B in pancreatic cancer progression Carbon monoxide-based anti-metastatic therapies MicroRNA regulation of tumor suppressors Epigenetic mechanisms in oncogenesis Tumor microenvironment interactions Publications (2024-2019) highlight advancements in: Murine cancer models Epigenetic metastatic drivers Nanotherapy approaches T cell infiltration in tumors miRNA-dysregulated pathways Bcl-xL mutation analysis Scientific honors include: Mildred L. and John F. Rasweiler Research Scholar in Cancer Research Current grants (2024-2027): DoD: Bcl-xL in breast cancer metastasis Manhasset Women's Coalition: CO-based breast cancer prevention NCI: RHAMM B in pancreatic cancer metastasis

Andres F. CorreaView profile

Associate Professor

• Urologic Oncology
• Kidney Cancer
• Bladder Cancer
• +7 more

Dr. Andres F. Correa is an Associate Professor and Director of Research at the Department of Urology, Fox Chase Cancer Center , Temple University Health System. He serves as the Society of Urologic Oncology Fellowship Director and specializes in urologic oncology with expertise in kidney, testicular, bladder, prostate, and penile cancers. Clinical Focus: Minimally invasive surgery, robotic laparoscopic techniques, and traditional open procedures Research: Development of prognostic models for kidney/bladder cancer, biomarker discovery in renal cell carcinoma Clinical Philosophy: Emphasizes patient education, individualized care, and multidisciplinary collaboration Research Trends: His 81+ publications (2012-2025) span surgical oncology, biomarker development, and health disparities in urology. Notable work includes nomogram validation for upper tract urothelial carcinoma and analyses of gender/racial gaps in oncology citations. Scientific Recognition: Listed in Philadelphia Magazine Top Doctors (2023-24) Clinical Innovations: Developed CT loopogram for post-cystectomy evaluation and pioneered approaches for hilar renal lesions. Active in translational research and clinical trials at Fox Chase Cancer Center.

David WeberView profile

Researcher

• Evolutionary Biology
• Reproductive Physiology
• Animal Behavior
• +3 more

David Weber is a Postdoctoral Research Associate at the University of Massachusetts Amherst, affiliated with the Department of Veterinary and Animal Sciences. He holds a PhD in Biology from the University of Maryland, where he worked with Dr. Heidi Fisher on mating strategies in Peromyscus mice, and earned his BSc and MSc in Biology from the University of New Orleans studying Anolis carolinensis ecology. His research focuses on fertilization mechanisms, co-evolution of reproductive traits, and postcopulatory sexual selection. Education: BSc & MSc in Biology (University of New Orleans), PhD in Biology (University of Maryland) Current Work: Investigating sperm-oocyte fusion dynamics under Dr. Pablo Visconti at UMass Research Themes: Co-evolution of reproductive traits, territorial behavior, sperm competition, and technological innovations in behavioral monitoring His recent publications explore sperm aggregation, fertilization mechanisms, and mating system impacts on physiological traits. He received the Lalor Foundation Fellowship to support his work. Contact: wweber@umass.edu .

Thomas E. AhleringView profile

Professor

• Urologic Oncology
• Robotic Surgery
• Prostate Cancer
• +7 more

Dr. Thomas E. Ahlering is a Professor and Vice Chairman in the Department of Urology at the University of California, Irvine (UCI) School of Medicine. He is a leading expert in urologic oncology, specializing in robotic radical prostatectomy for prostate cancer, with over 2,500 surgeries performed. He previously served as Chief of Urologic Oncology at City of Hope and Chief of Urology at UC Irvine. His clinical and research work has earned him recognition as one of America’s Best Doctors since 1994 and as a Top 2% Medical Scientist globally. Dr. Ahlering's research interests center on urologic oncology , particularly robotic surgery , functional recovery after prostatectomy , and patient-reported outcomes . He has pioneered techniques in nerve-sparing and urinary anastomosis to improve continence and potency. His work has significantly contributed to the adoption and refinement of da Vinci robotic systems in urologic surgery. His scholarly output includes over 400 publications, with recent work focusing on surgical innovation, international training, patient selection, and long-term oncological outcomes. The articles reflect a strong emphasis on improving surgical precision, minimizing complications, and enhancing quality of life. Themes include technological evolution, global dissemination of robotic techniques, and patient-centered care. Scientific recognition includes: Lifetime Achievement Award in Robotic Surgery (North American Robotic Urology Symposium) Outstanding Faculty Achievement – Lauds and Laurels (UCI Alumni Association) Mentor of the Year (UCI Institute of Clinical and Translational Science) Top 2% of Medical Scientists in the World (Stanford Study) Consistently listed in America’s Best Doctors since 1994 Dr. Ahlering has mentored numerous trainees and residents, contributing significantly to education in urologic oncology. His lab and surgical team, often referred to as "The A-Team," operate at MiVIP Surgical Center and are known for their high coordination, patient-centered approach, and expertise in robotic prostatectomy. He continues to lead innovation in urinary diversion techniques such as the Indiana pouch and ileal neobladder.

Sara O. VargasView profile

Associate Professor

• Pediatric Pathology
• Pulmonary Pathology
• Interstitial Lung Disease
• +4 more

Sara O. Vargas is an Associate Professor at Harvard Medical School and a practicing pediatric pathologist at Boston Children's Hospital. She holds an MD from University of Vermont College of Medicine and completed fellowships in Pediatric Pathology and Anatomic/Clinical Pathology. Harvard University (Undergraduate) University of Vermont College of Medicine (Medical School) Boston Children's Hospital (Pediatric Pathology Fellowship) Brigham and Women's Hospital (Anatomic/Clinical Pathology Fellowship) Her research focuses on pediatric pulmonary pathology, interstitial lung disease, and genetic determinants of congenital disorders. She has contributed extensively to understanding pulmonary hypertension mechanisms and imaging protocols for developmental lung conditions. Her recent publications address topics like genetic variants in interstitial lung disease, vascular remodeling in pulmonary hypertension, and multiomic analyses of sudden infant death. She serves as Director of Quality and Patient Safety in the Department of Pathology, which processes over 12,000 surgical pathology cases annually. Dr. Vargas specializes in the intersection of pathology, radiology, and clinical genetics, with particular expertise in: Pediatric pulmonary hypertension Congenital lung malformations Genetic lung disease Post-transplant pathology Interstitial lung disease Pediatric oncologic pathology

Vassilios PapadopoulosView profile

Professor

• Steroid Hormone Biosynthesis
• Neurosteroid Formation
• Endocrine Pathologies
• +7 more

Vassilios Papadopoulos serves as Dean of the USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences (formerly USC School of Pharmacy) and Interim Dean of the USC Suzanne Dworak-Peck School of Social Work . He holds the John Stauffer Dean’s Chair in Pharmaceutical Sciences and is a Professor of Pharmacology and Pharmaceutical Sciences at the University of Southern California. PhD from Université Pierre et Marie Curie (Paris) and undergraduate pharmacy degree from University of Athens Previously led research at McGill University Health Centre and Georgetown University Research Focus: Over 350 publications and two dozen patents on steroid biosynthesis mechanisms in adrenal glands, gonads, and brain. Investigates regulation by hormones, chemicals, and environmental factors like phthalates with applications in reproduction, aging, cancer, and neurological disorders. Academic Leadership: Expanded pharmacy education through new degree programs , state-of-the-art facilities , and diversity initiatives . Directed $300M+ research grants at McGill and established training centers. Scientific Awards: Fellowships in RSC , AAAS , AAPS , CAHS Foreign member of French National Academies of Medicine and Pharmacy Outstanding Dean Award (APhA-ASP 2025), Distinguished Andrologist (ASA 2020) Patents: Over 25 licensed inventions related to TSPO and steroidogenesis . Public Health Advocacy: Promoted pharmacist-led vaccination programs during the COVID-19 pandemic .

Alessandra AinsworthView profile

Assistant Professor

• Reproductive Endocrinology
• Infertility
• Fertility Preservation
• +5 more

Dr. Alessandra (Ali) Ainsworth is an Assistant Professor in the Department of Obstetrics and Gynecology at Mayo Clinic , specializing in Reproductive Endocrinology and Infertility . She serves as the IVF Director for the Mayo Clinic Division of Reproductive Endocrinology and Infertility. Medical School: University of Kansas Residency: Mayo Clinic (Obstetrics and Gynecology) Fellowship: Mayo Clinic (Reproductive Endocrinology and Infertility) Master's Degree: Biomedical Science (Mayo Clinic) Her research program focuses on long-term health outcomes after infertility and novel approaches to fertility care , particularly emphasizing patient experience improvement and expanded access to reproductive technologies . Clinical expertise spans Infertility , Fertility Preservation , and Complex Fertility Treatments . Recent publications analyze: Medical implications of ART in comorbid populations (pulmonary disease, epilepsy) Embryo development dynamics and attrition rates Reproductive immunology and hormonal biomarkers Societal fertility trends and pandemic impacts Imaging protocols for ovarian assessment Patient anxiety reduction techniques in fertility procedures Scientific contributions recognized through: Mayo Brothers Distinguished Fellowship Award (2021) Ann Harris Research Award (2018) Best Resident Educator in OB/GYN (2017) Daniel K Roberts Medical Student Award (2014) Membership in Alpha Omega Alpha and Arnold P. Gold Humanism in Medicine Society Professional leadership includes: Scientific Advisory Board (Flo Health) Institutional Review Board member OB/GYN Innovation Task Force participation Thesis Advisory Committee at Mayo Clinic Graduate School

Geoffrey W AbbottView profile

Professor

• Cardiac Electrophysiology
• Ion Channel Biology
• Arrhythmia Mechanisms
• +4 more

Geoffrey W. Abbott, PhD, is a Professor in the Department of Physiology & Biophysics at the University of California, Irvine School of Medicine. He holds dual leadership roles as Vice Dean for Basic Science Research and Senior Associate Dean for Academic Personnel. His research focuses on molecular mechanisms of cardiac arrhythmias, ion channel physiology, and genetic mutations affecting heart function. Key contributions include identifying Gsα mutations linked to ventricular tachycardia and exploring potassium channel activation via botanical compounds. Abbott’s work integrates genetics, pharmacology, and clinical insights to advance arrhythmia treatment strategies. Research Interests: Cardiac electrophysiology, ion channel dysfunction in disease, G-protein signaling, genetic mutations in arrhythmias, and therapeutic modulation of potassium channels using natural compounds. His lab investigates mechanisms underlying ventricular arrhythmias and develops novel treatments targeting ion channel dysregulation. Publications reflect a focus on channelopathies, ischemia/reperfusion injury, and the application of traditional medicines. His NIH-funded projects (R01 HL056139/HL066214) support studies on potassium channel regulation and arrhythmia mechanisms. Abbott also mentors faculty through academic leadership roles, fostering research and education initiatives at UCI.

Micah JacobsView profile

Associate Professor

• Pediatric Urology
• Congenital Urologic Abnormalities
• Spina Bifida Management
• +4 more

Dr. Micah Jacobs is an Associate Professor at the University of Texas Southwestern Medical Center's Department of Urology, where he also serves as Director of the Pediatric Urology Fellowship Program. He completed his medical degree at Yale School of Medicine, residency at Lahey Hospital & Medical Center, and a pediatric urology fellowship at Seattle Children’s Hospital, alongside a master’s in Public Health from the University of Washington. He is board-certified in Urology and actively involved in academic activities with the American Urological Association. His research focuses on congenital urologic abnormalities, Spina Bifida management, minimally invasive surgery, complex urologic reconstruction, and neurogenic bladder dysfunction. Notable work includes studies on long-term outcomes of surgical techniques in pediatric urology and the transition of Spina Bifida patients into adulthood. He co-directs the Adolescent to Adult Transition program at Texas Scottish Rite Hospital, specializing in spina bifida care. Dr. Jacobs’ publications span robotic surgery outcomes, surgical innovations in congenital anomalies, and clinical trials comparing antibiotic efficacy in renal infections. His work emphasizes improving surgical techniques and patient care standards in pediatric urology. He maintains clinical practices at Children’s Health Specialty Centers in Dallas, Plano, and Rockwall, and actively participates in teaching via the American Board of Urology review courses. No specific awards or grants are explicitly listed in the provided text.

J. (Jan) BogerdView profile

Assistant Professor

• Endocrinology
• Spermatogenesis
• Testicular Stem Cells
• +7 more

Dr. J. (Jan) Bogerd is an Assistant Professor in the Department of Biology at the Faculty of Science, Utrecht University, where he has been a key member of the Reproductive Biology Group since 1993. His research is centered in the field of Developmental Biology, with strong affiliations to the Biodynamics and Biocomplexity research area and the PtS – Future Food Utrecht initiative. His primary research interests include Endocrinology, Spermatogenesis, Testicular Stem Cells, Molecular Biology and Biochemistry of G Protein-Coupled Receptors, and the Relaxin Peptide Family and their Receptors . His work primarily uses zebrafish and other fish models to investigate the molecular and hormonal regulation of reproductive processes, particularly spermatogenesis and puberty. His extensive publication record, with over 145 research outputs, demonstrates a sustained focus on gonadotropin signaling, steroidogenesis, and the interplay between endocrine and paracrine factors in testicular function. Recent articles highlight ongoing work on Fsh, Igf, Wnt, and prostaglandin signaling in zebrafish spermatogenesis, as well as studies on puberty and gene expression in Atlantic salmon. His research often involves collaboration with prominent scientists like R. W. Schulz. PhD: Vrije Universiteit, Amsterdam (1988–1992); Thesis: 'Alternative splicing generates neuropeptide diversity in Lymnaea stagnalis' Post-doctoral Fellow: Utrecht University (1992–1993) Dr. Bogerd has not received any explicitly mentioned scientific awards in the provided text. He has supervised various research activities and has been involved in numerous collaborative projects, though specific details on grants and advisees are not listed. His work is fundamental to understanding the basic mechanisms of reproduction in fish, with potential implications for aquaculture and biomedical research.

Kerry McInnesView profile

Research Fellow

• Endocrinology
• Molecular Biology
• Metabolic Homeostasis
• +17 more

Kerry McInnes is a Research Fellow at UHI Moray, part of the University of the Highlands and Islands, where she contributes to the Just Transition initiative focused on Net Zero transition in the Moray region. She holds a PhD in biomedical sciences from the University of Edinburgh and is actively involved in research, project leadership, and community engagement. University: University of the Highlands and Islands Campus: UHI Moray Role: Doctor Research Fellow - Just Transition Email: kerry.mcinnes.moray@uhi.ac.uk ORCID: https://orcid.org/0000-0002-6637-5791 Accepting PhD Students: Yes Education: Doctor of Philosophy (PhD), University of Edinburgh, 2003 Research Interests: Kerry McInnes's research spans two major phases: early work in endocrinology and metabolism, and current work in sustainability and energy transition. Her expertise includes steroid hormone metabolism, adipose tissue biology, and reproductive endocrinology. She has transitioned into applied sustainability research, focusing on the implications of Net Zero policies on employment, skills development, and infrastructure. Her interdisciplinary approach integrates scientific research with stakeholder engagement, education, and policy development. Research Trends: Her recent publications show a shift from laboratory-based biomedical research to applied environmental and social research. While her early work (2004–2014) centered on molecular mechanisms in endocrinology, her recent activity (2022 onward) reflects engagement with renewable energy, climate action, and community-based sustainability projects. This evolution demonstrates a broadening of impact from cellular mechanisms to regional socio-economic transformation. Scientific Recognition: h-index: 17 (Scopus) 1025 Citations (Scopus) ORCID registered Work highlighted in news outlets, blogs, and social media Supervision and Funding: She is currently Principal Investigator (PI) on multiple active research and outreach projects, including the Scottish Offshore Wind Skills Portal, Futures in Wind, and the Speyside Living Lab. She has led projects on climate conversation, green infrastructure, and skills development for Net Zero transition. Her role as PI indicates leadership in grant acquisition and project management. She is accepting PhD students, suggesting active mentorship and supervision. Labs and Networks: She is a member of the Moray Climate Action Network and the Moray Hydrogen Steering Group, indicating active participation in regional sustainability networks. Her work is collaborative, involving partnerships across institutions and sectors to support just transition strategies.

Linda M GerberView profile

Professor

• Epidemiology
• Hypertension
• Socioeconomic and Ethnic Disparities in Health
• +7 more

Linda M Gerber, Ph.D., is Professor of Population Health Sciences in the Department of Population Health Sciences and Professor of Epidemiology in Medicine in the Department of Medicine at Weill Cornell Medical College, Weill Cornell Medicine. She has maintained continuous faculty appointments since 2005. Education Ph.D., University of Colorado (1978) M.A., University of Colorado (1976) B.A., State University of New York at Binghamton (1973) Research Interests Dr. Gerber is a nationally recognized expert in hypertension epidemiology, focusing on how psychological traits, ethnicity, socioeconomic status, and behavioral or genetic factors influence diurnal blood-pressure patterns and treatment responses. Her portfolio also encompasses traumatic brain injury, sodium-intake estimation, vitamin D deficiency, women’s midlife health, pediatric critical-care outcomes, and vaccine immunology. Across more than 150 peer-reviewed publications appearing from 1980 to 2025, her work clusters into four major domains: (1) cardiovascular risk factors—particularly hypertension and sodium intake—in diverse populations; (2) neurocritical care and rehabilitation after traumatic brain injury, including neuromodulation trials; (3) women’s health at midlife, examining body composition, menopausal symptoms, and vitamin D status; and (4) pediatric critical-care epidemiology, emphasizing delirium, health-services utilization, and quality of care. Grants & Projects Principal Investigator, ELASTIC Trial (NIMH, 2024–2025) Principal Investigator Subaward, CTSC-UL1 (NCATS, 2023–2025) Co-Investigator, multiple NIH-funded studies in neurocritical care and pediatric outcomes (2017–2027) Former Principal Investigator, NHLBI Neighborhood Study on ethnicity, SES, and blood-pressure rhythms Contact lig2002@med.cornell.edu